Small Molecules

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.

Oral solid dosage, HPAPIs, OSD development, OSD formulations, poorly soluble drugs, fixed-dose combinations, controlled release

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

So much has already been achieved with RNA – and it’s only going to get better.

Why mRNA will be a key disrupter in the coming years; experts from CureVac and Omega Therapeutics give their views.

With US courts consistently ruling in favor of the PrEP drug manufacture, the CDC and DHHS have had no choice but to be humble.

The industry is under pressure to reduce the risks of nitrosamines in both in-development and on-market drug products.

The trends and challenges in oral solid dosage formulations contribute to greater stability for drugs used by patients worldwide.

So you know your small molecule from your AAV, but can you unscramble the names of these 2024 novel drug approvals?

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.